Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only

Home/AK/Anchorage

Updated September 2026 from ClinicalTrials.gov

Paid Clinical Trials in Anchorage, AK

Q: Do I need to be sick to join a clinical trial in Anchorage?

No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.

Q: Are clinical trials in Anchorage safe?

Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.

Q: Is compensation for clinical trials taxable?

In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.

Q: How often do new paid studies open in Anchorage?

Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Anchorage.

Q: Can I be in more than one clinical trial at a time?

Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Anchorage typically complete one or two studies per year.

Studies commonly pay $75 to $4,500 per completed study

111 clinical trials are currently recruiting participants within 30 miles of Anchorage. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

111studies recruiting

1+research centers nearby

4condition categories

Live from the NIH registry

Studies recruiting near Anchorage right now

Top 25 of 111 recruiting studies, sorted by proximity — each links to its official registry page

The Alaska Oculocardiac Reflex Study

Bradycardia, Strabismus N/A Observational 4,000 participants sought

Alaska Children's EYE & Strabismus — Anchorage, Alaska (26.8 mi) · Sponsor: Alaska Blind Child Discovery

See eligibility & contact on ClinicalTrials.gov (NCT04353960)

Effect of Meal Timing During Cancer Treatment in Patients in Alaska: A Randomized Clinical Trial

Rectal Cancer Stage II, Rectal Cancer Stage III N/A Interventional 100 participants sought

Alaska Native Medical Center (ANMC) — Anchorage, Alaska (26.8 mi) · Sponsor: Fred Hutchinson Cancer Center

See eligibility & contact on ClinicalTrials.gov (NCT06802172)

Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)

Malignant Female Reproductive System Neoplasm, Malignant Solid Neoplasm Phase 2 Interventional 70 participants sought

Alaska Women's Cancer Care — Anchorage, Alaska (26.8 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT06126276)

BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease

HR+/HER2- Breast Cancer Phase 3 Interventional 1,056 participants sought

Alaska Oncology and Hematology, Llc — Anchorage, Alaska (26.8 mi) · Sponsor: BeOne Medicines

See eligibility & contact on ClinicalTrials.gov (NCT07492641)

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Phase 1, Phase 2 Interventional 960 participants sought

Providence Alaska Medical Center — Anchorage, Alaska (26.8 mi) · Sponsor: PedAL BCU, LLC

See eligibility & contact on ClinicalTrials.gov (NCT04726241)

Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma

Asthma Phase 3 Interventional 440 participants sought

Research Site — Anchorage, Alaska (26.8 mi) · Sponsor: AstraZeneca

See eligibility & contact on ClinicalTrials.gov (NCT06307665)

Group Music Therapy for Chronic Pain Management in Active Duty Service Members

Chronic Pain Phase 2 Interventional 130 participants sought

Joint Base Elmendorf-Richardson (JBER) — Anchorage, Alaska (26.8 mi) · Sponsor: Henry M. Jackson Foundation for the Advancement of Military Medicine

See eligibility & contact on ClinicalTrials.gov (NCT07755540)

Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors

Malignant Solid Neoplasm N/A Observational 2,062 participants sought

Anchorage Associates in Radiation Medicine — Anchorage, Alaska (26.8 mi) · Sponsor: SWOG Cancer Research Network

See eligibility & contact on ClinicalTrials.gov (NCT04871542)

EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)

Breast Cancer N/A Observational 1,800 participants sought

Katmai Oncology Group - Anchorage — Anchorage, Alaska (26.8 mi) · Sponsor: Exact Sciences Corporation

See eligibility & contact on ClinicalTrials.gov (NCT06401421)

Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL

Relapsed or Refractory Aggressive B-Cell Non-Hodgkins Lymphoma Phase 2 Interventional 130 participants sought

Alaska Oncology & Hematology, LLC — Anchorage, Alaska (26.8 mi) · Sponsor: Hoffmann-La Roche

See eligibility & contact on ClinicalTrials.gov (NCT06806033)

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

B Acute Lymphoblastic Leukemia Phase 3 Interventional 303 participants sought

Anchorage Associates in Radiation Medicine — Anchorage, Alaska (26.8 mi) · Sponsor: Alliance for Clinical Trials in Oncology

See eligibility & contact on ClinicalTrials.gov (NCT03150693)

Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Phase 3 Interventional 3,680 participants sought

Katmai Oncology Group — Anchorage, Alaska (26.8 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT06058377)

Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma

Metastatic Malignant Neoplasm in the Lung, Metastatic Osteosarcoma Phase 3 Interventional 62 participants sought

Providence Alaska Medical Center — Anchorage, Alaska (26.8 mi) · Sponsor: Children's Oncology Group

See eligibility & contact on ClinicalTrials.gov (NCT05235165)

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Phase 3 Interventional 2,130 participants sought

Research Site — Anchorage, Alaska (26.8 mi) · Sponsor: AstraZeneca

See eligibility & contact on ClinicalTrials.gov (NCT07431281)

Project: Every Child for Younger Patients With Cancer

Adrenal Gland Pheochromocytoma, Carcinoma In Situ N/A Observational 75,000 participants sought

Providence Alaska Medical Center — Anchorage, Alaska (26.8 mi) · Sponsor: Children's Oncology Group

See eligibility & contact on ClinicalTrials.gov (NCT02402244)

More Outside Your Door: a Diet/physical Activity Intervention to Decrease Risk of Obesity in Alaska Native Preschoolers

Child Obesity N/A Interventional 450 participants sought

Alaska Native Tribal Health Consortium — Anchorage, Alaska (26.8 mi) · Sponsor: Alaska Native Tribal Health Consortium

See eligibility & contact on ClinicalTrials.gov (NCT06303544)

Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer

Miscellaneous Neoplasm, Nos, Non-Neoplastic Condition, Nos N/A Interventional 535 participants sought

Anchorage Associates in Radiation Medicine — Anchorage, Alaska (26.8 mi) · Sponsor: Alliance for Clinical Trials in Oncology

See eligibility & contact on ClinicalTrials.gov (NCT07091617)

School Screening and Telemedicine Specialty Referral to Address Childhood Hearing Loss in Rural Alaska

Hearing Loss N/A Interventional 8,060 participants sought

Southcentral Foundation — Anchorage, Alaska (26.8 mi) · Sponsor: University of Arkansas

See eligibility & contact on ClinicalTrials.gov (NCT05593484)

A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer

HER2-positive Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Phase 3 Interventional 840 participants sought

Research Site — Anchorage, Alaska (26.8 mi) · Sponsor: AstraZeneca

See eligibility & contact on ClinicalTrials.gov (NCT06764875)

Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia

Recurrent B Acute Lymphoblastic Leukemia, Recurrent B Lymphoblastic Lymphoma Phase 2 Interventional 80 participants sought

Providence Alaska Medical Center — Anchorage, Alaska (26.8 mi) · Sponsor: Children's Oncology Group

See eligibility & contact on ClinicalTrials.gov (NCT02981628)

A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

Endometrial Cancer Phase 3 Interventional 1,123 participants sought

Alaska Women's Cancer Care ( Site 6036) — Anchorage, Alaska (26.8 mi) · Sponsor: Merck Sharp & Dohme LLC

See eligibility & contact on ClinicalTrials.gov (NCT06952504)

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia Phase 2 Interventional 461 participants sought

Providence Alaska Medical Center — Anchorage, Alaska (26.8 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT04546399)

Metabolism-Informed Care to Aid Alaska Native People to Quit Smoking (QUIT)

Smoking Cessation N/A Interventional 50 participants sought

Anchorage Native Primary Care Center — Anchorage, Alaska (26.8 mi) · Sponsor: Southcentral Foundation

See eligibility & contact on ClinicalTrials.gov (NCT06556238)

Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers

Pancreatic Neoplasm N/A Observational 770 participants sought

Anchorage Associates in Radiation Medicine — Anchorage, Alaska (26.8 mi) · Sponsor: ECOG-ACRIN Cancer Research Group

See eligibility & contact on ClinicalTrials.gov (NCT04239573)

A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)

Non-small Cell Lung Cancer Phase 3 Interventional 868 participants sought

Alaska Oncology and Hematology ( Site 0039) — Anchorage, Alaska (26.8 mi) · Sponsor: Merck Sharp & Dohme LLC

See eligibility & contact on ClinicalTrials.gov (NCT06077760)

Actively enrolling

Studies you may be able to join near Anchorage

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Google-rated

Top-rated research centers in Anchorage

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Aurora Clinical Research

9500 Independence Dr, Anchorage, AK 99507

(907) 759-7559

Website

Clinical trials in Anchorage: what's recruiting

The Anchorage area currently has 111 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Anchorage, the most active research areas are:

Cancer & Oncology15 studies
Lungs & Breathing1 studies
Liver & Kidney1 studies
Diabetes & Metabolism1 studies

Every listing shows the study phase, the recruiting site and its distance from Anchorage, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Anchorage

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Anchorage participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

Do I need to be sick to join a clinical trial in Anchorage?

No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.

Are clinical trials in Anchorage safe?

Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.

Is compensation for clinical trials taxable?

In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.

How often do new paid studies open in Anchorage?

Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Anchorage.

Can I be in more than one clinical trial at a time?

Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Anchorage typically complete one or two studies per year.

Paid clinical trials near Anchorage

Other metros within reach

Bremerton, WA1,467 Olympia, WA224 Marysville, WA199 Seattle, WA1,492 Tacoma, WA1,445 Bellevue, WA1,500 Vancouver, WA1,016 Salem, OR111

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

Get free trial alerts